While the total angio lab procedure volume has been relatively stable, the procedure mix has broadened.
Des Plaines, IL (PRWEB) December 15, 2011
The growth rate for interventional procedures being performed in U.S. angiography labs has fallen to 1% annually, according to a newly released report by market research firm IMV Medical Information Division. Fewer sites are buying brand-new systems, and in coming years hospitals most likely will focus on replacing existing systems.
According to IMV’s recent census of angio labs in the U.S., an estimated 4.9 million procedures were performed at 1,710 angio lab sites in 2010, including noncoronary vascular angiographic and other procedures.
From 2008 to 2010, total procedures performed in angio labs grew approximately 2%, from 4.8 million in 2008 to 4.9 million procedures in 2010 for hospitals with 150 or more beds, resulting in an average annual growth rate of about 1%. The pace of angio lab procedure growth has slowed compared with the prior four-year period from 2004 to 2008, when total procedures grew at an average annual growth rate of approximately 4.6%, from 4.0 million to 4.8 million.
“While the total angio lab procedure volume has been relatively stable, the procedure mix has broadened,” observed Lorna Young, senior director, market research. “From 2004 to 2010, the number of peripherally inserted central catheter line/vascular access, vertebroplasty, sacroplasty, kyphoplasty, biopsy, radiofrequency (RF) tumor ablation, and other RF studies has contributed to the overall volume of procedures performed in angio labs.”
Young said the market outlook for the next two to three years looks relatively stable, as hospitals seek to retool their older angio labs.
"About 40% of the hospitals with 150 or more beds are planning to purchase labs from 2011 through 2013, with more than 90% of the planned angio lab purchases having flat-panel digital detectors," Young said. "This is comparable to the 41% of angio lab sites reported in IMV’s prior 2008/2009 study.”
IMV's 2011 Interventional Angiography Lab Market Summary Report describes trends in procedures, angio lab x-ray systems, contrast media utilization, power injectors for angio contrast, capital and contrast media budgets, and site operations characteristics. IMV’s report also includes market forecast scenarios for 2011-2015, incorporating varying assumptions about the first-buyer, replacement, and additional unit purchases that are based on market indicators identified in the report. Other report highlights:
- 52% of angio lab sites have one room, 31% have two rooms, and 17% have three or more rooms.
- About three-quarters of planned purchases are for replacement units, and one-quarter will be additional units.
- Angio lab sales in the future will primarily consist of new units, with 98% of the planned units being new and 2% planned to be refurbished/used units.
- In addition to interventional radiologists using the angio suite, vascular surgeons are the second most likely physician type to be using angio labs, performing procedures in more than 60% of the angio lab sites.
IMV’s 2011 Interventional Angiography Census Database provides comprehensive profiles of U.S. hospitals with 150 or more beds performing interventional angiography procedures, where at least 50% of the total lab volume consists of noncoronary angiography procedures. IMV's 2011 Interventional Angiography Lab Market Summary Report is available with the database license or as a separate purchase. For more information about IMV’s Interventional Angiography Census Database and Market Summary Report, visit the corporate website at http://www.imvinfo.com or call 847-297-1404 to speak with a representative.
IMV Medical Information Division is a marketing research and consulting firm founded in 1977, specializing in medical imaging and other advanced healthcare technology markets. IMV's marketing consulting services, in combination with its census databases of U.S. imaging sites with selected modalities, provide clients valuable assistance in strategic planning, customer satisfaction, product development, and sales initiatives.